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Benefit	of	vaccination	in	protecting		
the	departments	of	Grand’Anse,	Ouest	and	Sud	against	a	
potential	second	epidemic	wave	of	cholera		 23	December	2016		This	work	is	presented	as	a	collaboration	between	Epicentre	Paris-Genève	and	the	Laboratory	of	Ecohydrology	of	the	Ecole	Polytechnique	Férédale	de	Lausanne1.	
	
	
This	is	analysis	uses	cholera	and	rainfall	data	available	up	to	epi	week	43;	model	
predictions	presented	herein	are	subject	to	change	when	further	updated	as	
additional	data	become	available.			
Introduction		In	a	previous	report	[1],	we	presented	model	projections	based	on	data	available	up	to	epi-week	43	(ending	Oct-29).	These	projections	suggested	that,	due	to	anticipated	heavy	rainfalls	at	the	end	of	November,	a	second	peak	of	cholera	might	be	observed	in	early	December	in	the	departments	of	Grand’Anse	and	Sud,	with	potential	propagation	to	other	departments.		These	projections	supported	the	strategy	of	the	MSPP2	OCV3	campaign	to	vaccinate	800,000	people	in	these	two	departments,	which	were	also	the	areas	most	affected	by	damage	from	Hurricane	Mathew	in	early	October.		Eventually,	the	vaccine	campaign	took	place	from	11	to	18	November	but	heavy	rainfall	was	not	recorded	in	late	November	and	no	second	wave	of	cholera	was	observed.	In	this	context,	the	benefits	of	the	vaccine	campaign	are	difficult	to	assess	since	the	limited	spread	is	likely	the	result	of	non-favourable	environmental	conditions	and	the	reduction	of	the	susceptible	population	thanks	to	the	immunization	campaign.		Here	we	show	that,	had	heavy	rainfall	occurred	in	late	November	and	early	December	2016(as	NOAA	was	forecasting	in	late	October),	the	vaccine	campaign	was	effectively	designed	to	considerably	reduce	the	risk	of	a	second	epidemic	wave	in	Grand’Anse	and	Sud,	with	more	limited	effects	in	Ouest	department.	
																																																								1EPFL	(Enrico	Bertuzzo,	Flavio	Finger,	Damiano	Pasetto)	designed	the	model	and	performed	the	analysis.	Epicentre	(Anton	Camacho,	Sandra	Cohuet,	Francesco	Grandesso,	Francisco	Luquero,	Emily	Lynch)	produced	the	report	and	recommendations.	Both	teams	interpreted	model	results.	Epicentre	team	is	funded	by	MSF.	2Ministère	de	la	Santé	Publique	et	de	la	Population	3Oral	Cholera	Vaccine	
Objectives	of	the	analysis		To	assess	the	impact	of	the	OCV	vaccine	campaign	in	mitigating	the	risk	of	a	second	epidemic	wave	of	cholera,	given	anticipated	heavy	rainfall,	in	the	departments	of	Grand’Anse,	Ouest	and	Sud.	
Results		The	model	was	calibrated	to	cholera	[2]	and	rainfall	[3]	data	available	up	to	epi-week	43.		The	model	was	then	projected	through	the	end	of	January	2017	using	a	rainfall	forecast	obtained	from	the	National	Oceanic	and	Atmospheric	Administration	[4].	This	projection	was	done	with	and	without	accounting	for	the	vaccine	campaign	that	took	place	from	11	to	18	November.			The	figure	below	shows	that	without	vaccination	(in	green)	a	second	epidemic	peak,	potentially	larger	than	the	one	following	Hurricane	Matthew,	could	have	been	expected	in	early	December,	following	rainfall	in	late	November.	However,	the	same	model,	reforecast	to	account	for	the	vaccine	campaign	(in	red)	shows	a	more	reassuring	scenario,	with	both	the	median	and	95%	credible	interval	forecasting	the	second	epidemic	wave	as	smaller	than	the	first	in	Grand’Anse	and	Sud.	By	contrast,	the	vaccine	campaign	has	only	a	limited	effect	in	reducing	the	forecasted	number	of	cases	in	Ouest,	suggesting	that	the	dynamics	in	this	department	is	rather	self-sustained.		To	quantify	the	benefit	of	vaccination,	we	computed	the	probability	that	the	second	epidemic	wave	would	be	“bigger”	than	the	first	one	according	to	two	criteria:	1) Maximum	number	of	cases	at	the	peak.	2) Total	number	of	cases	during	the	epidemic	wave.		The	results	are	presented	in	the	table	below	and	show	that	the	risk	of	having	a	second	peak	higher	than	the	first	one	decreases	from	~30%	to	~3%	in	Grand’Anse	and	from	~50%	to	~3%	in	Sud.	In	comparison,	the	risk	of	a	higher	second	peak	in	Ouest	was	less	likely	(16.5%)	but	is	only	slightly	reduced	(14.5%)	by	the	vaccine	campaign,	due	to	indirect	effects	(e.g.	less	introduction	of	cholera	from	Grand’Anse	and	Sud	to	Ouest).	The	benefits	are	similar	when	considering	the	total	number	of	cases.			Our	analysis	shows	that	given	the	data	available	before	the	OCV	campaign,	the	targeted	departments	were	the	ones	at	highest	risk	of	having	a	second	peak	of	cholera	early	December.	By	contrast,	a	second	epidemic	peak	was	much	less	likely	in	other	departments,	like	Ouest.	Furthermore,	our	results	suggest	that,	for	at	least	the	short	term,	the	OCV	campaign	targeted	enough	people	in	Grand’Anse	and	Sud	to	prevent	a	resurgence	of	a	cholera	peak	in	case	of	heavy	rainfalls.	However,	the	OCV	campaign	would	have	had	a	limited	effect	on	reducing	that	risk	in	other	departments,	mainly	because,	once	introduced,	cholera	transmission	is	self-sustained.	
	Operational	recommendation	based	on	model	results		 - Although	model	results	suggest	the	number	of	cholera	cases	in	Grand’Anse	and	Sud	should	keep	declining	after	OCV	campaign,	there	is	still	a	risk	of	localised	outbreaks	for	at	least	2	reasons:	
o Coverage	might	be	less	than	100%	as	assumed	in	the	model.	
o Coverage	might	be	heterogeneous,	with	pockets	of	susceptibility	remaining	within	vaccinated	areas.	- Several	departments	in	Haiti,	including	Ouest,	Artibonite	and	North,	remain	at	moderate	risk	of	increased	transmission	in	the	following	weeks	and	close	monitoring	of	the	cholera	trends	in	these	departments	is	required.		
	
Figure	1	Model	projections	in	Grand'Anse,	Ouest	and	le	Sud	based	on	rainfall	forecast	and	with	(red)	
or	without	(green)	accounting	for	the	OCV	vaccine	campaign	that	occurred	from	11	to	18	November	
(grey	bar).	Top	panels:	black	points	represent	data	on	which	the	model	is	calibrated,	solid	lines	are	
median	fit/forecast	of	weekly	number	of	cholera	cases	and	shaded	envelopes	are	associated	95%	
credible	intervals.	Bottom	panels:	historical	(blue)	and	forecast	(red)	rainfall	data	from	NOAA,	in	
mm/day.	Note	that	the	y-axis	is	cut	to	100	mm/day	and	the	rainfall	peak	is	annotated.		
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Table	1	Change	in	probability	of	observing	a	bigger	second	epidemic	wave	following	heavy	rainfall	
according	to	two	different	criteria.	Department	 Criteria	 Probability	2nd	wave	is	bigger	without	vaccination	 Probability	2nd	wave	is	bigger	with	vaccination	 Percentage	point	difference	Grand’Anse	 Peak	size	 30.9%	 3.2%	 27.7	Total	cases	 18%	 0.6%	 17.4	Ouest	 Peak	size	 16.5%	 14.7%	 1.8	Total	cases	 14.7%	 12.5%	 2.2	Sud	 Peak	size	 49.3%	 2.7%	 46.6	Total	cases	 36.5%	 0.6%	 35.9		
Method		We	refer	to	our	previous	report	[1]	for	a	brief	description	of	the	model	and	calibration	procedures.	Here	we	briefly	explain	how	the	OCV	campaign	was	modelled.	We	assumed	that	vaccination	would	target	individuals	independently	of	their	cholera	infection	history	(i.e.	both	susceptible	and	already	immune	individuals	are	eligible).	The	OCV	provides	immunity	starting	with	a	delay	of	one	week.	Vaccinated	individuals	already	immune	are	assumed	to	remain	completely	immune,	while	vaccinated	susceptibles	benefit	from	a	leaky	immunity	with	63%	efficacy	(thus	reducing	the	susceptibility	by	63%).	Due	to	the	short	time	horizon	of	the	forecast,	at	this	stage	no	assumption	is	made	for	the	duration	of	the	vaccine-induced	immunity.	We	obtained	the	list	of	the	communes	targeted	by	the	single	dose	OCV	campaign	in	Grand’Anse	and	le	Sud.	As	this	analysis	was	completed	prior	to	having	actual	coverage	data,	we	assumed	a	maximum	coverage	rate	per	commune	of	100%,	with	800,000	doses	distributed.	The	model	assumes	a	linear	ramp-up	of	vaccine	uptake	between	11	and	18	of	November.			
Why	model	forecasts	might	not	be	so	accurate?		 - The	forecast	reliability	of	the	model	is	dependent	on	the	validity	and	quality	of	the	data	used,	which	is	limited	to	what	is	currently	available	in	the	post-hurricane	context.	The	cholera	surveillance	network	of	Haiti	has	been	affected	by	the	hurricane,	with	many	areas	remaining	inaccessible	and	many	health	facilities	having	sustained	significant	damage	that	is	affecting	their	operations.	Moreover,	cholera	cases,	particularly	at	the	community	level,	may	be	underreported	in	some	areas.	The	data	may	therefore	not	represent	the	true	dynamics	of	the	ongoing	epidemic.	- The	model	disregards	several	known	mechanisms	of	cholera	transmission,	for	which	empirical	data	is	lacking:	
o Variations	in	local	water	and	sanitation	risk	factors	related	to	both	chronic	and	post-hurricane	conditions.	
o Specific	population	displacements	following	the	hurricane,	which	may	not	be	properly	accounted	for	by	the	human	mobility	network	algorithm	used	in	the	model.	- Rainfall	forecasts	of	up	to	a	month	in	advance	might	not	be	reliable.	- The	model	outputs	might	be	highly	sensitive	to	the	prior	parameter	distribution	used	to	initialize	the	ensemble.	A	sensitivity	analysis	has	not	been	performed	yet	to	prove	the	robustness	of	the	forecast.	- The	vaccine	efficacy	of	the	Euvichol	oral	cholera	vaccine	has	not	yet	been	estimated.	For	this	work,	we	used	recently	published	[5]	estimates	of	63%	for	single	dose	efficacy	of	another	oral	vaccine,	Shanchol.	- The	duration	of	immunity	provided	by	the	vaccine	is	not	known.	Although	for	the	short	term	this	should	not	affect	our	forecast	(immunity	is	believed	to	last	at	least	one	year),	it	may	have	an	impact	on	the	longer	term	validity	of	model	predictions.	- In	this	model	we	assumed	a	100%,	homogeneous	vaccine	coverage	in	the	targeted	communes.	In	reality,	vaccine	coverage	is	less	than	100%	and	likely	to	be	heterogeneous,	which	may	have	an	impact	on	the	outcome	of	vaccination,	as	pockets	of	susceptibility	can	trigger	localised	outbreaks	that	are	not	accounted	for	by	the	model.		
As	more	data	becomes	available,	the	model	will	be	updated	and	re-calibrated,	thus	
increasing	its	forecast	reliability.		
Ongoing	modelling	work		 - We	are	currently	working	on	more	precise	inclusion	of	the	variability	of	the	rainfall	forecast	from	NOAA	which,	every	6	hours,	updates	forecasts	for	9	months	ahead.	Because	of	the	chaotic	dynamics	of	weather,	these	forecasts	can	differ	substantially	at	different	time	points.	To	make	more	robust	predictions,	we	are	working	on	using	an	ensemble	of	rainfall	forecasts	from	NOAA.				
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